Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 58.46 USD 2.87% Market Closed
Market Cap: $2.7B

Multiples-Based Value

The Multiples-Based Value of one HAE stock under the Base Case scenario is 99.74 USD. Compared to the current market price of 58.46 USD, Haemonetics Corp is Undervalued by 41%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HAE Multiples-Based Value
Base Case
99.74 USD
Undervaluation 41%
Multiples-Based Value
Price $58.46
Worst Case
Base Case
Best Case

Multiples Across Competitors

HAE Competitors Multiples
Haemonetics Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Haemonetics Corp
NYSE:HAE
2.7B USD 2.1 15.6 8.8 12.7
JP
Hoya Corp
TSE:7741
9.5T JPY 10.3 37.8 27.3 32.8
CH
Alcon AG
SIX:ALC
29.4B CHF 3.5 37.6 14.5 28.2
US
Medline Inc
NASDAQ:MDLN
35.6B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
99.8B DKK 3.5 24.4 12.9 15.4
US
Align Technology Inc
NASDAQ:ALGN
12.3B USD 3 29.9 12.8 17.6
CA
Bausch + Lomb Corp
NYSE:BLCO
5.8B USD 1.1 -16 17.1 55.4
JP
Asahi Intecc Co Ltd
TSE:7747
932.1B JPY 7.2 52.9 25.1 34.1
CN
Intco Medical Technology Co Ltd
SZSE:300677
39.2B CNY 4 23 34.4 34.4
UK
ConvaTec Group PLC
LSE:CTEC
4.3B GBP 2.3 32.5 11.4 17.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
37B CNY 8.1 22.2 19.9 19.9
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett